Dubovichenko M.V., Nedorezova D.D., Patra C., Drozd V.S., Andrianov V.S., Ashmarova A.I., Nnanerugo V., El-Deeb A.A., Kolpashchikov D.M. Marker-dependent cleavage of RNA by binary (split) DNAzyme (BiDz) and binary DNA machines (BiDNM). не указано. 2024. pp. in press?.
Patra C.K., Smirnov V.V., Drozd V.S., Hussein Z., Rybalko D.S., Kozlova A.V., Nour M., Zemerova T.P., Kolosova O.S., Kalnin A.Y., El-Deeb A. Towards the Development of a DNA Automaton: Modular RNA-cleaving Deoxyribozyme Logic Gates Regulated by miRNAs. Analyst. 2024. Vol. 149. No. 6. pp. 1947-1957.
DNA construct based on DNAzymes for selective SNP detection in KRAS
Selective DNA-machine for SNP Detection in KRAS
OPTIMIZATION OF AFFINITY AND STABILITY OF SELECTED APTAMER FOR BSA
Development of DNA-based Machines for Selective Detection of Cancer-associated RNA
Genotyping of Cancer-associated KRAS Mutation by Deoxyribozyme Based 4-arms DNA Machine
Development Deoxyribozyme Based Machine for Genotyping of Cancer-associated KRAS Mutation
Towards Intracellular Overexpression and Mutation Recognition
Patra C., Eldeeb A.A. Thresholding DNA nanomachine as a highly cooperative and efficient enzyme-like system for controlled RNA cleavage. ChemMedChem. 2023. Vol. 18. No. 7. pp. e202300040.
Использование триазиниламидофосфата для внутриклеточной доставки АСО и сложных ДНК-конструкций//OpenBio
Towards DNA-robot for Auto Diagnosis and Cancer Treatment
Development of a DNA-based Nanoconstruction to Detect Low Concentrations of Cancer-associated Molecules
DESIGN OF A DNA MACHINE BASED ON SHRNA FOR MARKER-DEPENDENT RNA INTERFERENCE
DETECTION OF NUCLEIC ACID BASED CANCER MARKERS INSIDE THE CELL
INVESTIGATION OF INTRACELLULAR DELIVERY OF THERAPEUTIC NUCLEIC ACIDS WITH THE HELP OF LIPID CONJUGATES AND DNA NANOSTRUCTURES
Oncomarker modulated RNA cleavage Using threshold Binary DNAzyme
AN shRNA RELEASING DNA NANOSTRUCTURE WITH ONCOMARKER-DEPENDENT ACTIVATION
КОНСТРУКЦИИ НА ОСНОВЕ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ ШИРОКОГО СПЕКТРА ПРИМЕНЕНИЙ
COOPERATIVITY FOR CANCER TREATMENT: A THRESHOLDING DNA LOGIC GATE THAT IS ACTIVE AT HIGH CONCENTRATIONS OF CANCER MARKER RNA